SurModics Inc. (SRDX) Hits New 52-Week High at $27.81
SurModics Inc. (NASDAQ:SRDX) shares hit a new 52-week high on Tuesday . The stock traded as high as $27.81 and last traded at $27.69, with a volume of 91,553 shares traded. The stock had previously closed at $27.06.
SRDX has been the topic of several research analyst reports. Zacks Investment Research upgraded SurModics from a “hold” rating to a “buy” rating and set a $21.00 target price on the stock in a research note on Tuesday, April 5th. TheStreet raised SurModics from a “hold” rating to a “buy” rating in a research report on Tuesday, April 26th. Finally, Barrington Research lifted their price target on SurModics from $27.00 to $30.00 and gave the stock an “outperform” rating in a research report on Tuesday, May 3rd.
The company has a 50 day moving average price of $24.45 and a 200 day moving average price of $21.26. The stock has a market capitalization of $361.22 million and a P/E ratio of 41.39.
SurModics (NASDAQ:SRDX) last released its quarterly earnings results on Thursday, July 28th. The company reported $0.37 EPS for the quarter, topping analysts’ consensus estimates of $0.12 by $0.25. The firm had revenue of $19.97 million for the quarter, compared to analyst estimates of $16.31 million. During the same quarter last year, the company earned $0.30 earnings per share. The firm’s revenue for the quarter was up 25.6% on a year-over-year basis. Equities analysts forecast that SurModics Inc. will post $1.04 earnings per share for the current year.
In other SurModics news, SVP Bryan K. Phillips sold 1,816 shares of the company’s stock in a transaction on Tuesday, June 14th. The stock was sold at an average price of $23.44, for a total transaction of $42,567.04. Following the transaction, the senior vice president now directly owns 25,350 shares in the company, valued at $594,204. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website.
A hedge fund recently raised its stake in SurModics stock. Dimensional Fund Advisors LP increased its stake in shares of SurModics Inc. (NASDAQ:SRDX) by 0.4% during the fourth quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 515,134 shares of the company’s stock after buying an additional 1,970 shares during the period. Dimensional Fund Advisors LP owned 3.96% of SurModics worth $10,442,000 at the end of the most recent reporting period.
SurModics, Inc is a provider of surface modification and in vitro diagnostic technologies to the healthcare industry. The Company operates through two segments: Medical Device and In Vitro Diagnostics. The Company is focused on to transform its medical device business from being a provider of coating technologies to offering whole product solutions to medical device customers.
Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.